Factors of early protective action of live influenza vaccine combined with recombinant bacterial polypeptides against homologous and heterologous influenza infection

We are developing an associated vaccine based on live influenza vaccine (LAIV) and streptococcal recombinant peptides. The recombinant group B streptococcus (GBS) peptides P6 and ScaAB demonstrated a distinguished immunomodulating effect in THP-1 cells. The increase in IFN 1-alpha expression after S...

Descripción completa

Detalles Bibliográficos
Autores principales: Desheva, Yulia A., Leontieva, Galina F., Kramskaya, Tatiana A., Landgraf, Galina O., Sychev, Ivan A., Rekstin, Andrey R., Suvorov, Alexander N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6365543/
https://www.ncbi.nlm.nih.gov/pubmed/30839941
http://dx.doi.org/10.1016/j.heliyon.2019.e01154

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6365543/
https://www.ncbi.nlm.nih.gov/pubmed/30839941
http://dx.doi.org/10.1016/j.heliyon.2019.e01154

Ejemplares similares